Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01272024 · ClinicalTrials.gov registry record · Phase 3
An Intervention to Improve Outcomes in Patients With Advanced Cancer
A Phase 3 study of Cancer, sponsored by Yale University.
- Completed
- Registry status
- Phase 3
- Development phase
- 146
- Enrollment target
- 1
- Study location
NCT01272024 is a Phase 3 study of Cancer that has completed, run by Yale University. The registered enrollment target is 146 participants, below the 3,491-participant average among 615 other Cancer trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state.
The verdict
NCT01272024, a Phase 3 study of Cancer, has completed, sponsored by Yale University.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 146 participants
- Enrollment target
- 1
- Study location
Study Summary
1.) To integrate discharge planning into an intervention provided by advanced practice nurses (APRNs)for patients with advanced cancer, 2.) To evaluate the effects of the intervention, and 3.) To explore the reach, adoption, and implementation of the intervention to facilitate the transition of patients from surgery/biopsy/chemotherapy to medical oncology in a comprehensive cancer center.
Conditions Studied
Interventions
- BEHAVIORAL Intervention
- BEHAVIORAL Symptom Education
Study Locations (1)
Connecticut
- Yale New Haven Hospital/Smilow Cancer Hospital - New Haven
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 146 participants |
| Start Date | 2009-09 |
| Est. Completion | 2013-08 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01272024
The ClinicalTrials.gov registry entry for NCT01272024 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 146 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,491-participant average among 615 other Cancer trials with a reported enrollment target (96% lower). The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Cancer appearing as the primary indexed condition, and to 2 interventions - of which Intervention is the first listed.
NCT01272024 reports 1 study location spanning 1 distinct geographic area - top geographies include Connecticut.
Frequently Asked Questions
What is clinical trial NCT01272024 about?
NCT01272024 is a clinical study titled "An Intervention to Improve Outcomes in Patients With Advanced Cancer". 1.) To integrate discharge planning into an intervention provided by advanced practice nurses (APRNs)for patients with advanced cancer, 2.) To evaluate the effects of the intervention, and 3.) To explore the reach, adoption, and implementation of the intervention to facilitate the transition of pati...
What is the current status of trial NCT01272024?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 146 participants. The study started on 2009-09. Estimated completion is 2013-08.
What conditions does trial NCT01272024 study?
This clinical trial studies the following conditions: Cancer.
What interventions are being tested in trial NCT01272024?
The interventions under investigation include: Intervention (BEHAVIORAL), Symptom Education (BEHAVIORAL).
Who is sponsoring clinical trial NCT01272024?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01272024 being conducted?
This trial has 1 study location across Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Spiritual Care or Psychotherapy Versus Palliative Care Alone in Patients With Non-Curative Malignancies
RECRUITING · Phase 3
-
DOAC - Dosing Options in AntiCoagulation Prophylaxis
RECRUITING · Phase 3
-
Abatacept in Immune Checkpoint Inhibitor Myocarditis
RECRUITING · Phase 3
-
Post-Discharge Risk-Based Management in Patients Undergoing High-Risk Elective Major Cancer Operations (PRS II)
RECRUITING · Phase 3
-
A Randomized Controlled Trial of Inhaled Tranexamic Acid for the Treatment of Pulmonary Hemorrhage in Cancer Patients
RECRUITING · Phase 3
-
Evaluation of a Telehealth Oncofertility Care Intervention in Adolescent and Young Adult Cancer Patients
RECRUITING · Phase 3
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.